Stephen Joel Coons, PhD

Professor Emeritus
Pharmacy Practice & Science
FAX: 520-547-3456
Critical Path Institute

Dr. Coons' research program focuses on the assessment of outcomes resulting from medical care interventions. His particular interest is measuring the impact of pharmaceutical products on patient-reported functioning and well-being. Along with being a professor in the College of Pharmacy and the Mel & Enid Zuckerman College of Public Health, Dr. Coons served as co-director of the Arizona Cancer Center’s Behavioral Measurements Shared Service. In addition to his academic degrees, Dr. Coons completed a hospital pharmacy residency at the VA Medical Center in Phoenix and postdoctoral training in health outcomes research at the University of California, San Diego (UCSD). His previous academic appointments were in the colleges of pharmacy, medicine, and allied health professions at the University of Kentucky and in the Division of Health Care Sciences at the UCSD School of Medicine. Dr. Coons is a fellow in the American Association of Pharmaceutical Scientists. Upon retiring from the UA in June 2009, Dr. Coons became director of the Critical Path Institute’s Patient-Reported Outcome (PRO) Consortium.


BS, University of Connecticut, 1979
MS, University of Arizona, 1984
M Ed, University of Arizona, 1985
PhD, University of Arizona, 1986


Selected Publications

Hays RD, Kallich JD, Mapes D, Coons SJ, Carter WB. Development of the Kidney Disease Quality of Life (KDQOL) instrument. Quality of Life Research 1994;3:329-338.

Sheahan SL, Coons SJ, Robbins CA, Martin SS, Hendricks J, Latimer M. Psychoactive medication, alcohol use, and falls among older adults. Journal of Behavioral Medicine 1995;18:127-140.

Johnson JA, Nowatzki TE, Coons SJ. Health-related quality of life of diabetic Pima Indians. Medical Care 1996;34:97-102.

Hughes TE, Kaplan RM, Coons SJ, Draugalis JR, Johnson JA, Patterson TL. Construct validity of the Quality of Well-Being Scale and the MOS-HIV-34 Health Survey in HIV-infected patients. Medical Decision Making 1997;17:439-446.

Johnson JA, Coons SJ, Hays RD. The structure of satisfaction with pharmacy services. Medical Care 1998;36:244-250.

Coons SJ, Al-Abdulmohsin SA, Draugalis JR, Hays RD. Reliability of the Arabic version of the RAND-36 Health Survey and its equivalence with the US English version. Medical Care 1998; 36:428-432.

Johnson JA, Coons SJ. Comparison of the EQ-5D and SF-12 in an adult US sample. Quality of Life Research 1998;7:155-166.

Anderson JP, Kaplan RM, Coons SJ, Schneiderman LJ. Comparison of the Quality of Well-Being Scale and the SF-36 results among two samples of ill adults: AIDS and other illnesses. Journal of Clinical Epidemiology 1998;51:755-762.

Coons SJ, Rao S, Keininger DL, Hays RD. A comparative review of generic quality of life instruments. PharmacoEconomics 2000;17:13-35.

Johnson JA, Ohinmaa A, Murti B, Sintonen H, Coons SJ. Comparison of Finnish- and US-based VAS valuations of the EQ-5D measure. Medical Decision Making 2000;20:281-289.

Cox ER, Jernigan C, Coons SJ, Draugalis JR. Medicare beneficiaries’ management of capped prescription benefits. Medical Care 2001;39:296-301.

Yu J, Coons SJ, Draugalis JR, Ren XS, Hays RD. Equivalence of the Chinese and U.S.-English versions of the SF-36 Health Survey. Quality of Life Research 2003;12:449-457.

Shaw JW, Johnson JA, Coons SJ. US valuation of the EQ-5D health states: development and testing of the D1 model. Medical Care 2005;43:203-220.

Johnson JA, Luo N, Shaw JW, Kind P, Coons SJ. Valuations of EQ-5D health states: are the US and UK different? Medical Care 2005;43:221-228.

Luo N, Johnson JA, Shaw JW, Feeny D, Coons SJ. Self-reported health status of the adult US population as assessed by the EQ-5D and Health Utilities Index. Medical Care 2005;43: 1078-1086.

Shaw JW, Johnson JA, Levin JR, Coons SJ. Racial/ethnic differences in preferences for the EQ-5D health states: results from the US population valuation study. Journal of Clinical Epidemiology 2007;60:479-490.

Luo N, Johnson JA, Shaw JW, Coons SJ. A comparison of EQ-5D index scores derived from the US and UK population-based scoring functions. Medical Decision Making 2007;27:321-326.

Nyman JA, Barleen NA, Dowd BE, Russell DW, Coons SJ, Sullivan PW. Quality-of-life weights for the U.S. population: self-reported health status and priority health conditions, by demographic characteristics. Medical Care 2007;45:618-628.

Coons SJ, Chongpison Y, Wendel CS, Grant M, Krouse RS. Overall quality of life and difficulty paying for ostomy supplies in the VA Ostomy Health-Related Quality of Life Study: an exploratory analysis. Medical Care 2007;45:891-895.

Ramachandran S, Lundy JJ, Coons SJ. Testing the measurement equivalence of paper and touch-screen versions of the EQ-5D visual analog scale (EQ VAS). Quality of Life Research 2008; 17:1117-1120.

Luo N, Johnson JA, Shaw JW, Coons SJ. Relative efficiency of the EQ-5D, HUI2, and HUI3 index scores in measuring health burden of chronic medical conditions in a population health survey in the United States. Medical Care 2009;47:53-60.

Lundy JJ, Coons SJ, Wendel CS, Hornbrook MC, Herrinton LJ, Grant M, Krouse RS. Exploring household income as a predictor of psychological well-being among long-term colorectal cancer survivors. Quality of Life Research 2009;18:157-161.

Coons SJ, Gwaltney CJ, Hays RD, Lundy JJ, Sloan JA, Revicki DA, Lenderking WR, Cella D, Basch E. Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force Report. Value in Health 2009;12:419-429.

Luo N, Ko Y, Johnson JA, Coons SJ. The association of survey language (Spanish vs. English) with Health Utilities Index and EQ-5D index scores in a United States population sample. Quality of Life Research 2009;18:1377-1385.

Shaw JW, Pickard AS, Shengsheng Yu MS, Chen S, Iannacchione VG, Johnson JA, Coons SJ. A median model for predicting United States population-based EQ-5D heath state preferences. Value in Health. 2010;13: 278-288.

Luo N, Johnson JA, Coons SJ. Using instrument-defined health state transitions to estimate minimally important differences for four preference-based health-related quality of life instruments. Medical Care 2010;48:365-371.


Originally posted: September 9, 2013
Last updated: September 3, 2015
Want to update? Contact Webmaster
Share This